SMTL ID : 6uyf.1

Structure of Hepatitis C Virus Envelope Glycoprotein E2mc3-v1 redesigned core from genotype 6a bound to broadly neutralizing antibody AR3B

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.06 Å

Oligo State

hetero-1-1-1-mer

Ligands

2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG-NAG.1: 4 residues within 4Å: Chain A: V.104 Chain B: Y.33 Chain C: N.19, S.21 1 PLIP interactions: 1 interactions with chain B Hydrogen bonds: B:S.30 NAG-NAG.2: 5 residues within 4Å: Chain C: N.111, S.112, T.113, F.115, K.117 No protein-ligand interaction detected (PLIP)

1 x NAG- NAG- BMA- MAN: alpha-D-mannopyranose-(1-3)-beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose

NAG-NAG-BMA-MAN.3: 2 residues within 4Å: Chain C: N.91, T.93 No protein-ligand interaction detected (PLIP)

1 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)

NAG.4: 5 residues within 4Å: Chain A: V.54, T.55 Chain C: H.10, N.12, W.88 2 PLIP interactions: 2 interactions with chain A Hydrogen bonds: A:T.55, A:T.55

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

He, L. et al., Proof of concept for rational design of hepatitis C virus E2 core nanoparticle vaccines. Sci Adv (2020)

Release Date

2020-04-22

Peptides

Fab AR3B heavy chain: A
Fab AR3B light chain: B
Envelope glycoprotein E2: C

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
H

B
L

C
E

Fab AR3B heavy chain

Fab AR3B light chain

Envelope glycoprotein E2

Related Entries With Identical Sequence